2'-O-4'-C-Locked-G(dmf) Phosphoramidite
2'-O-4'-C-Locked-G(dmf) Phosphoramidite - N (Normal) / 0.25g / 30mL screwed bottle-28 is backordered and will ship as soon as it is back in stock.
Couldn't load pickup availability
Shipping notes
Shipping notes
Products in shop.hongene.com currently can only ship to the United States and Canada. For other regions, please visit contact us page to leave us a message or contact our regional sales.
Processing Time: within 2 business days, if available.
Delivery Time:- US: 3-8 business days (FedEx Standard).
- Canada: 5-10 business days (excludes customs delays).
Note: Delays due to force majeure like customs, natural disasters, or strikes are beyond our liability.
Excerpt from Shipping Policy
Details
Details
Basic Information
Locked Nucleic Acid (LNA) was first described by Wengel and coworkers in 1998 as a novel class of conformationally restricted oligonucleotide analogs
LNA is a bicyclic nucleic acid in which a ribonucleoside is linked to a methylene moiety between the 2'-oxygen and 4'-carbon atoms.
Oligonucleotides containing LNA exhibit unprecedented thermal stability to complementary DNA and RNA, allowing for excellent mismatch discrimination.
Application
LNA phosphoramidites, including 2'-O-4'-C-Locked-G(dmf) Phosphoramidite, offer multiple applicatoin due to their features:
- The high binding affinity of LNA oligos allows the use of short probes in applications such as SNP genotyping, allele-specific PCR and mRNA sample preparation.
- LNA is recommended for use in any hybridization assay that requires high specificity and/or reproducibility, such as double-labeled probes, in situ hybridization probes, molecular beacons, and PCR primers.
- LNA offers the ability to customize the Tm values of primers and probes in multiplexed assays.
As a result of these important properties, the use of LNA-modified oligos in antisense drug design is now being investigated, and recently the therapeutic potential of LNA has been explored.
Other Notes
LNA can be mixed with DNA and RNA, as well as other nucleic acid analogs, modifiers and labels. LNA oligonucleotides are water soluble and can be separated by gel electrophoresis and precipitated by ethanol.
Specifications
Specifications
-
Catalog No.PR2-005PR2-005PR2-005PR2-005PR2-005PR2-005PR2-005PR2-005
-
SMILESO=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1
-
Molecular FormulaC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8P
-
Molecular Weight852.93852.93852.93852.93852.93852.93852.93852.93
-
AppearanceOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matter
-
PurityHPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%
-
Storage Condition-20℃-20℃-20℃-20℃-20℃-20℃-20℃-20℃
Documentation
Documentation
Basic Information
Locked Nucleic Acid (LNA) was first described by Wengel and coworkers in 1998 as a novel class of conformationally restricted oligonucleotide analogs
LNA is a bicyclic nucleic acid in which a ribonucleoside is linked to a methylene moiety between the 2'-oxygen and 4'-carbon atoms.
Oligonucleotides containing LNA exhibit unprecedented thermal stability to complementary DNA and RNA, allowing for excellent mismatch discrimination.
Application
LNA phosphoramidites, including 2'-O-4'-C-Locked-G(dmf) Phosphoramidite, offer multiple applicatoin due to their features:
- The high binding affinity of LNA oligos allows the use of short probes in applications such as SNP genotyping, allele-specific PCR and mRNA sample preparation.
- LNA is recommended for use in any hybridization assay that requires high specificity and/or reproducibility, such as double-labeled probes, in situ hybridization probes, molecular beacons, and PCR primers.
- LNA offers the ability to customize the Tm values of primers and probes in multiplexed assays.
As a result of these important properties, the use of LNA-modified oligos in antisense drug design is now being investigated, and recently the therapeutic potential of LNA has been explored.
Other Notes
LNA can be mixed with DNA and RNA, as well as other nucleic acid analogs, modifiers and labels. LNA oligonucleotides are water soluble and can be separated by gel electrophoresis and precipitated by ethanol.
-
Catalog No.PR2-005PR2-005PR2-005PR2-005PR2-005PR2-005PR2-005PR2-005
-
SMILESO=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1O=C1C(N=CN2[C@H]3[C@H](OC4)[C@H](OP(OCCC#N)N(C(C)C)C(C)C)[C@@]4(COC(C5=CC=CC=C5)(C6=CC=C(OC)C=C6)C7=CC=C(OC)C=C7)O3)=C2N=C(/N=C/N(C)C)N1
-
Molecular FormulaC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8PC44H53N8O8P
-
Molecular Weight852.93852.93852.93852.93852.93852.93852.93852.93
-
AppearanceOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matterOff-white to yellow powder,free from visible foreign matter
-
PurityHPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%HPLC≥98.0%
-
Storage Condition-20℃-20℃-20℃-20℃-20℃-20℃-20℃-20℃